JANX

Janux Therapeutics, Inc. - Common Stock (JANX)

About Janux Therapeutics, Inc. - Common Stock (JANX)

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Details

Daily high

$18.24

Daily low

$16.02

Price at open

$18.18

52 Week High

$35.34

52 Week Low

$12.12

Market cap

1.1B

Dividend yield

Volume

893,123

Avg. volume

755,955

P/E ratio

-11.06

Janux Therapeutics, Inc. - Common Stock News